YARW
Yarrow Bioscience Inc
22.50$
-6.9%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -339.9% | -616.5% | -495.6% | -14,695.5% | -653.0% | -6,054.5% | -6,121.6% | -5,976.7% | -6,780.8% | -5,811.2% | |
| – | 0.6% | 0.2% | 0.2% | 158.0% | 1.6% | 11.7% | 15.1% | – | 0.8% | 4.0% | |
| – | 85.0% | 31.7% | 34.2% | 1,512.6% | 86.2% | 867.9% | 900.8% | 779.5% | 659.3% | 404.9% | |
| – | 1,642.1% | -15.8% | -39.2% | 427.1% | -192.1% | 513.0% | 477.4% | 14.2% | 997.8% | -1,437.5% | |
| – | 4.6% | 0.6% | 1.3% | 2.5% | 0.5% | 0.0% | 0.0% | 0.0% | 23.4% | 0.0% | |
| – | -5,562.3% | -328.8% | -318.4% | 9,339.5% | 424.5% | 110.3% | 3,284.5% | -13,526.9% | 4,663.7% | 6,555.8% | |
| – | – | – | – | – | – | – | – | – | -28.1% | – | |
| – | – | 1,080.1% | 1,183.4% | 1,127.3% | 294.4% | 4,272.5% | 346.5% | 19,432.5% | -28.1% | -25.1% | |
| – | -5,902.2% | 134.9% | 369.4% | -4,228.7% | 65.9% | -1,671.6% | -2,490.6% | -71.0% | -2,145.3% | 719.5% | |
| – | -344.5% | -617.1% | -496.9% | -14,698.0% | -653.5% | -6,054.5% | -6,121.6% | -5,976.7% | -6,804.2% | -5,811.2% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.